SCHEMBL6287427

SCHEMBL6287427

CC(=O)NCCCC[C@@](N)(C(=O)Cc1c[nH]c2ccccc12)C(=O)Nc1ccc(C(c2ccc(NC(=O)[C@@](N)(CCCCNC(C)=O)C(=O)Cc3c[nH]c4ccccc34)cc2)c2ccc(NC(=O)[C@@](N)(CCCCNC(C)=O)C(=O)Cc3c[nH]c4ccccc34)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
LMNA P02545 2/20 0.47
CYP1A2 P05177 1/20 0.47
PKM P14618 1/20 0.47
TSHR P16473 1/20 0.47
CYP2C19 P33261 1/20 0.47
BLM P54132 1/20 0.47
ALDH1A1 P00352 2/20 0.44
MAPT P10636 4/20 0.43
ALOX12 P18054 1/20 0.42
HTT P42858 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.40
GOT1 P17174 4/20 0.40
HRH3 Q9Y5N1 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6286770 0.90 GOT1 (0.41) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL6287996 0.89 CTSL (0.41) MEN1KMT2ALMNAALDH1A1MAPT
Hydrochloric Acid SCHEMBL6290971 0.88 MC4R (0.43) ALDH1A1MAPTL3MBTL1HRH3
Hydrochloric Acid SCHEMBL6286771 0.88 MC4R (0.43) ALDH1A1MAPTL3MBTL1HRH3
SCHEMBL7030590 0.84 MTNR1A (0.41) MEN1KMT2ALMNACYP1A2TSHR
Trifluoroacetic Acid SCHEMBL6290842 0.84 MC3R (0.44) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL6288077 0.84 MAPK8 (0.42) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL6287787 0.83 L3MBTL1 (0.44) MEN1KMT2ALMNACYP1A2CYP2C19
SCHEMBL6287689 0.83 L3MBTL1 (0.44) MEN1KMT2ALMNAALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL6287929 0.83 MC4R (0.43) MEN1KMT2ALMNAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK MEN1 111/4885KMT2A 2704/4885LMNA 3699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.